These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19655038)

  • 41. Interpreting treatment-effect estimates with heterogeneity and choice: simulation model results.
    Brooks JM; Fang G
    Clin Ther; 2009 Apr; 31(4):902-19. PubMed ID: 19446162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bias testing, bias correction, and confounder selection using an instrumental variable model.
    Yeob Choi B; Fine JP; Alan Brookhart M
    Stat Med; 2020 Dec; 39(29):4386-4404. PubMed ID: 32854161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interpretation of correlations in clinical research.
    Hung M; Bounsanga J; Voss MW
    Postgrad Med; 2017 Nov; 129(8):902-906. PubMed ID: 28936887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Appropriate use of gastrointestinal-protective agents in elderly needs clarification.
    Cavalieri TA
    J Am Osteopath Assoc; 1999 Jun; 99(6):301-2. PubMed ID: 10405515
    [No Abstract]   [Full Text] [Related]  

  • 45. [Instrumental variable analysis].
    Boef AG; le Cessie S; Dekkers OM
    Ned Tijdschr Geneeskd; 2013; 157(4):A5481. PubMed ID: 23343737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Joint mixed-effects models for causal inference with longitudinal data.
    Shardell M; Ferrucci L
    Stat Med; 2018 Feb; 37(5):829-846. PubMed ID: 29205454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing the impact of unmeasured confounders for credible and reliable real-world evidence.
    Zhang X; Stamey JD; Mathur MB
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1219-1227. PubMed ID: 32929830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Time dependent hazard ratio estimation using instrumental variables without conditioning on an omitted covariate.
    MacKenzie TA; Martinez-Camblor P; O'Malley AJ
    BMC Med Res Methodol; 2021 Mar; 21(1):56. PubMed ID: 33743583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Using instrumental variables to estimate the attributable fraction.
    Dahlqwist E; Kutalik Z; Sjölander A
    Stat Methods Med Res; 2020 Aug; 29(8):2063-2073. PubMed ID: 31640504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bridging preference-based instrumental variable studies and cluster-randomized encouragement experiments: Study design, noncompliance, and average cluster effect ratio.
    Zhang B; Heng S; MacKay EJ; Ye T
    Biometrics; 2022 Dec; 78(4):1639-1650. PubMed ID: 34051117
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding the Assumptions Underlying Instrumental Variable Analyses: a Brief Review of Falsification Strategies and Related Tools.
    Labrecque J; Swanson SA
    Curr Epidemiol Rep; 2018; 5(3):214-220. PubMed ID: 30148040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of rational nonsteroidal anti-inflammatory drugs and gastro-protective agents use; association rule data mining using outpatient prescription patterns.
    Pattanaprateep O; McEvoy M; Attia J; Thakkinstian A
    BMC Med Inform Decis Mak; 2017 Jul; 17(1):96. PubMed ID: 28676124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implementation of Instrumental Variable Bounds for Data Missing Not at Random.
    Marden JR; Wang L; Tchetgen EJT; Walter S; Glymour MM; Wirth KE
    Epidemiology; 2018 May; 29(3):364-368. PubMed ID: 29394191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort.
    Bonde AN; Martinussen T; Lee CJ; Lip GYH; Staerk L; Bang CN; Bhattacharya J; Gislason G; Torp-Pedersen C; Olesen JB; Hlatky MA
    Circ Cardiovasc Qual Outcomes; 2020 Apr; 13(4):e006058. PubMed ID: 32283966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Causal inference accounting for unobserved confounding after outcome regression and doubly robust estimation.
    Genbäck M; de Luna X
    Biometrics; 2019 Jun; 75(2):506-515. PubMed ID: 30430543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient study.
    Valkhoff VE; van Soest EM; Masclee GM; de Bie S; Mazzaglia G; Molokhia M; Kuipers EJ; Sturkenboom MC
    Aliment Pharmacol Ther; 2012 Oct; 36(8):790-9. PubMed ID: 22928490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bias, Confounding, and Interaction: Lions and Tigers, and Bears, Oh My!
    Vetter TR; Mascha EJ
    Anesth Analg; 2017 Sep; 125(3):1042-1048. PubMed ID: 28817531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reducing the variance of the prescribing preference-based instrumental variable estimates of the treatment effect.
    Abrahamowicz M; Beauchamp ME; Ionescu-Ittu R; Delaney JA; Pilote L
    Am J Epidemiol; 2011 Aug; 174(4):494-502. PubMed ID: 21765169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Instrumental variable analysis to estimate treatment effects: a simulation study showing potential benefits of conditioning on hospital.
    Ceyisakar IE; van Leeuwen N; Steyerberg EW; Lingsma HF
    BMC Med Res Methodol; 2022 Apr; 22(1):121. PubMed ID: 35468748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Instrumental variable analysis of multiplicative models with potentially invalid instruments.
    Shardell M; Ferrucci L
    Stat Med; 2016 Dec; 35(29):5430-5447. PubMed ID: 27527517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.